Literature DB >> 29968322

IL-1RA VNTR and IL-1α 4845G>T polymorphisms and risk of idiopathic male infertility in Iranian men: A case-control study and an in silico analysis.

Tayyebeh Zamani-Badi1, Hossein Nikzad1, Mohammad Karimian2.   

Abstract

This study aimed to investigate the association of IL-1RA VNTR and IL-1α 4845G>T polymorphisms with idiopathic male infertility followed by an in silico analysis. In a case-control study, we collected blood samples from 230 infertile and 230 healthy men. Genotyping of IL-1RA VNTR was performed by PCR whereas IL-1α 4845G>T was genotyped by polymerase chain reaction-restriction fragment length polymorphism. An in silico approach was employed for the detection of IL-1RA VNTR and IL-1α 4845G>T effects on some molecular aspects of IL-1RA and IL-1α respectively. The result of our genetic association study for IL-1α 4845G>T revealed that there was a significant association between GT genotype, TT genotype, T allele and idiopathic male infertility. Although there was no significant association between IL-1RA VNTR and male infertility in the overall analysis. However, subgroup analysis revealed that the subjects with VNTR 4R/5R genotype were at a higher risk of oligozoospermia. Furthermore, 4845TT genotype, and 4845T allele were associated with oligozoospermia, asthenozoospermia and nonobstructive azoospermia. Bioinformatics analysis showed that IL-1RA VNTR may affect the splicing pattern of IL-1RA. Moreover, IL-1α 4845G>T has a significant effect on RNA structure and protein function. Based on our findings, both IL-1RA VNTR and IL-1α 4845G>T polymorphisms could be considered as potential biomarkers for screening of susceptible individuals.
© 2018 Blackwell Verlag GmbH.

Entities:  

Keywords:  IL-1RA; IL-1α; genetic polymorphism; idiopathic male infertility; in silico analysis

Mesh:

Substances:

Year:  2018        PMID: 29968322     DOI: 10.1111/and.13081

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  8 in total

Review 1.  Oxidative Stress and Idiopathic Male Infertility.

Authors:  Pallav Sengupta; Shubhadeep Roychoudhury; Monika Nath; Sulagna Dutta
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Genetics and molecular biology of male infertility among Iranian population: an update.

Authors:  Majid Mojarrad; Ehsan Saburi; Alireza Golshan; Meysam Moghbeli
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Association of PON1-L55M Genetic Variation and Breast Cancer Risk: A Case-Control Trial.

Authors:  Amir Farmohammadi; Ali Momeni; Banafshe Bahmani; Hossein Ghorbani; Ramin Ramzanpour
Journal:  Asian Pac J Cancer Prev       Date:  2020-01-01

4.  Androgen receptor (AR)-CAG trinucleotide repeat length and idiopathic male infertility: a case-control trial and a meta-analysis.

Authors:  Narges Mobasseri; Faezeh Babaei; Mohammad Karimian; Hossein Nikzad
Journal:  EXCLI J       Date:  2018-12-17       Impact factor: 4.068

5.  Methionine Synthase Reductase-A66G and -C524T Single Nucleotide Polymorphisms and Prostate Cancer: A Case-Control Trial

Authors:  Atefeh Basir
Journal:  Asian Pac J Cancer Prev       Date:  2019-05-25

Review 6.  Genetic Landscape of Nonobstructive Azoospermia and New Perspectives for the Clinic.

Authors:  Miriam Cerván-Martín; José A Castilla; Rogelio J Palomino-Morales; F David Carmona
Journal:  J Clin Med       Date:  2020-01-21       Impact factor: 4.241

7.  Association Analysis of Methylenetetrahydrofolate Reductase Common Gene Polymorphisms with Breast Cancer Risk in an Iranian Population: A Case-Control Study and a Stratified Analysis.

Authors:  Mohammad Karimian; Nasrin Rezazadeh; Tahereh Khamehchian
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01

8.  Association of ApaI and TaqI polymorphisms in VDR Gene with Breast Cancer.

Authors:  Amir Hassan Matini; Negar Jafarian-Dehkordi; Banafshe Bahmani; Mehran Sharifi; Danial Jahantigh; Tahereh Mazoochi
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.